Related Experiment Video
Updated: Apr 22, 2026

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
Advances and strategies in NADPH oxidase inhibitors and activators patents
Abstract:
The NADPH oxidase (NOX) enzymes were identified as a family of seven isoforms contributing to the production of reactive oxygen species. During the past 15 years, this class of enzymes has increasingly gained interest from the academic and pharmaceutical laboratories. Extensive research efforts focused on the decryption of their mechanism of action has shown that Nox enzymes are the most important source of reactive oxygen species and key contributors in the pathogenesis of several diseases. Recent publications and patents suggest that NOX modulators may provide major opportunities in many diseases as novel therapeutics. This review covers application patents and current state-of-the-art on Nox modulators from 2005 to December 2013 and examines the different approaches patented to modulate the activity of Nox enzymes.
Insights
NADPH oxidase (NOX) enzymes are key producers of reactive oxygen species and implicated in disease. NOX modulators show therapeutic potential, with numerous patents filed between 2005 and 2013.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- NADPH oxidase (NOX) enzymes are a family of seven isoforms.
- NOX enzymes are significant sources of reactive oxygen species (ROS).
- NOX enzymes play a crucial role in the pathogenesis of various diseases.
Purpose of the Study:
- To review application patents and the state-of-the-art of NOX modulators.
- To examine patented approaches for modulating NOX enzyme activity.
- To highlight the therapeutic potential of NOX modulators.
Main Methods:
- Literature review of patents and publications from 2005 to December 2013.
- Analysis of patented strategies for NOX enzyme modulation.
- Synthesis of current knowledge on NOX modulators.
Main Results:
- NOX enzymes are central to ROS production and disease development.
- Significant research interest in NOX enzymes from academic and pharmaceutical sectors.
- Numerous patents demonstrate diverse approaches to modulate NOX activity.
Conclusions:
- NOX modulators represent promising therapeutic opportunities for various diseases.
- Understanding NOX enzyme mechanisms is critical for drug development.
- Patented strategies offer insights into targeting NOX for novel treatments.
More Related Videos
Related Concept Videos
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Phase I Oxidative Reactions: Overview
Peroxisomes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Bioactivation and Tissue Toxicity

